🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Suet Kee Loo

University of Pittsburgh

ORCID: 0000-0002-4558-1967

Also affiliated with UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “A Novel Neoplastic Fusion Transcript, RAD51AP1-DYRK4 , Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers”.

A Novel Neoplastic Fusion Transcript, RAD51AP1-DYRK4 , Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2769
N/A
0DataRank · unranked
17 citations

Jamunarani Veeraraghavan, Ying Tan, Jinah Kim, Xian Wang, Suet Kee Loo +4 more

Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2961
N/A
0DataRank · unranked
12 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jin-Ah Kim +13 more

Fusion‐associatedcarcinomas of the breast: Diagnostic, prognostic, and therapeutic significance

Genes Chromosomes and Cancer(2022)10.1002/gcc.23029
N/A
0DataRank · unranked
29 citations

Megan E. Yates, Sichun Yang, Steffi Oesterreich, Adrian V. Lee, Xiao‐Song Wang +1 more

Data from Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

(2023)10.1158/1078-0432.c.6531045
N/A
0DataRank · unranked
0 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jinah Kim +13 more

Data from A Novel Neoplastic Fusion Transcript, RAD51AP1-DYRK4, Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers

(2023)10.1158/1078-0432.c.6530286
N/A
0DataRank · unranked
0 citations

Jamunarani Veeraraghavan, Ying Tan, Jinah Kim, Xian Wang, Suet Kee Loo +4 more

Rapid and Sensitive Digital Droplet PCR Assays for Detecting HPV16 DNA in Liquid Biopsies

Journal of Medical Virology(2024)10.1002/jmv.70146
N/A
0DataRank · unranked
2 citations

Jian Feng, Carly Reeder, D. Elias, Zhongping Xu, Yufei Huang +5 more

CASTOR1 phosphorylation as a predictor of survival in male patients with KRAS-mutated lung adenocarcinoma.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.e20015
N/A
0DataRank · unranked
0 citations

Gabriel Sica, Xian Wang, Tingting Li, Luping Chen, Autumn Gaither‐Davis +5 more

Unraveling CASTOR1's tumor suppressive role: Genetic ablation of CASTOR1 and KRAS-driven mouse model of non-small cell lung cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.8528
N/A
0DataRank · unranked
0 citations

Shenyu Sun, Suet Kee Loo, Luping Chen, Ling Ding, Tingting Li +5 more

CASTOR1 : A Novel Tumor Suppressor Linking mTORC1 and KRAS Pathways in Tumorigenesis and Resistance to KRAS-Targeted Therapies in Non-Small Cell Lung Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.23.650349
N/A
0DataRank · unranked
2 citations

Ling Ding, Shenyu Sun, Suet Kee Loo, Luping Chen, Tingting Li +5 more